Viewing Study NCT02171104


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2026-06-28 @ 8:30 PM
Study NCT ID: NCT02171104
Status: RECRUITING
Last Update Posted: 2025-08-03
First Post: 2014-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mucopolysaccharidosis Disorders View
None Hurler Syndrome View
None Hunter Syndrome View
None Maroteaux Lamy Syndrome View
None Sly Syndrome View
None Alpha-Mannosidosis View
None Fucosidosis View
None Aspartylglucosaminuria View
None Glycoprotein Metabolic Disorders View
None Sphingolipidoses View
None Recessive Leukodystrophies View
None Globoid Cell Leukodystrophy View
None Metachromatic Leukodystrophy View
None Niemann-Pick B View
None Niemann-Pick C Subtype 2 View
None Sphingomyelin Deficiency View
None Peroxisomal Disorders View
None Adrenoleukodystrophy With Cerebral Involvement View
None Zellweger Syndrome View
None Neonatal Adrenoleukodystrophy View
None Infantile Refsum Disease View
None Acyl-CoA Oxidase Deficiency View
None D-Bifunctional Enzyme Deficiency View
None Multifunctional Enzyme Deficiency View
None Alpha-methylacyl-CoA Racmase Deficiency View
None Mitochondrial Neurogastrointestingal Encephalopathy View
None Severe Osteopetrosis View
None Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation) View
None Inherited Metabolic Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None allogeneic hematopoietic cell transplantation View
None bone marrow transplantation View
None IMD View
None AMACRD View
None MNGIE View
None HDLS View
None OP View
None ALD View